1. Guest editorial: leukemia stem cell

   • Koichi Akashi

   Progress in Hematology 12 November 2013 Pages: 625 - 626

2. TIM-3 as a novel therapeutic target for eradicating acute myelogenous leukemia stem cells

   • Yoshikane Kikushige
   • Toshihiro Miyamoto

   Progress in Hematology 18 September 2013 Pages: 627 - 633

   

3. Modeling normal and malignant human hematopoiesis in vivo through newborn NSG xenotransplantation

   • Fumihiko Ishikawa

   Progress in Hematology 21 November 2013 Pages: 634 - 640

   

4. Stem cell maintenance and disease progression in chronic myeloid leukemia

   • Takahiro Ito

   Progress in Hematology 04 April 2013 Pages: 641 - 647

   

5. Role of DNMT3A, TET2, and IDH1/2 mutations in pre-leukemic stem cells in acute myeloid leukemia

   • Steven M. Chan
   • Ravindra Majeti

   Progress in Hematology 15 August 2013 Pages: 648 - 657

   

6. Reduced intensity conditioning and co-transplantation of unrelated peripheral stem cells combined with umbilical cord mesenchymal stem/stroma cells for young patients with refractory severe aplastic anemia

   • Yuewen Fu
   • Qian Wang
   • Yongping Song

   Original Article 22 November 2013 Pages: 658 - 663

7. Secondary central nervous system involvement in 599 patients with diffuse large B-cell lymphoma: are there any changes in the rituximab era?

   • Lijuan Deng
   • Yuqin Song
   • Chen Zhang

   Original Article 14 November 2013 Pages: 664 - 671

   

8. Plasma cell leukaemia and HIV co-infection: profile of patients and experience at Universitas Academic Hospital in Bloemfontein, South Africa

   • Mubarak Ariyo Bidmos
   • Sunette Joubert
   • Vernon J. Louw

   Original Article 21 November 2013 Pages: 672 - 680

9. Excision repair cross-complementing group 2/Xeroderma pigmentousm complementation group D (ERCC2/XPD) genetic variations and susceptibility to diffuse large B cell lymphoma in Egypt

   • Mennat Allah Kamal El-Din
   • Mervat Mamdooh Khorshied
   • Ola M. Reda Khorshid

   Original Article 21 November 2013 Pages: 681 - 686

10. Long-term outcome of immunosuppressive therapy for Japanese patients with lower-risk myelodysplastic syndromes

    • Tomoko Hata
    • Hideki Tsushima
    • Yasushi Miyazaki

    Original Article 20 November 2013 Pages: 687 - 693

    

11. High incidence and severity of injection site reactions in the first cycle compared with subsequent cycles of subcutaneous bortezomib

    • Tomohiko Kamimura
    • Toshihiro Miyamoto
    • Koichi Akashi

    Original Article 19 November 2013 Pages: 694 - 701

    

12. Influence of pre-hydration and pharmacogenetics on plasma methotrexate concentration and renal dysfunction following high-dose methotrexate therapy

    • Masakatsu Yanagimachi
    • Hiroaki Goto
    • Shumpei Yokota

    Original Article 16 November 2013 Pages: 702 - 707

13. Substitution of cyclophosphamide in the modified BuCy regimen with fludarabine is associated with increased incidence of severe pneumonia: a prospective, randomized study

    • Dai-hong Liu
    • Lan-ping Xu
    • Xiao-jun Huang

    Original Article 17 November 2013 Pages: 708 - 715

    

14. Improving cytopenia with splenic artery embolization in a patient with paroxysmal nocturnal hemoglobinuria on eculizumab

    • Suresh K. Krishnan
    • Anita Hill
    • Richard J. Kelly

    Case Report 25 October 2013 Pages: 716 - 718

    

15. Deferasirox treatment improved hematopoiesis and led to complete remission in a patient with pure red cell aplasia

    • Minoru Kojima
    • Shinichiro Machida
    • Kiyoshi Ando

    Case Report 26 October 2013 Pages: 719 - 722

    

16. Successful treatment of POEMS syndrome with bortezomib and dexamethasone, combined with radiotherapy, and followed by autologous stem cell transplantation

    • Yoshimi Ishii
    • Etsuko Yamazaki
    • Yoshiaki Ishigatsubo

    Case Report 29 October 2013 Pages: 723 - 728

    

17. Erratum to: Chronic adult primary immune thrombocytopenia (ITP) in the Asia-Pacific region

    • Lai Heng Lee
    • Priscilla Caguioa
    • Beng H. Chong

    Erratum 13 November 2013 Pages: 729 - 729